Isoangustone A, A Novel Licorice Compound, Inhibits Cell Proliferation by Targeting PI3K, MKK4, and MKK7 in Human Melanoma
Authors:
- Eunjung LeeELEunjung Lee
- Sanguine ByunSanguine Byun
- Jong-Eun KimJKJong-Eun Kim
- Madhusoodanan MottamalMMMadhusoodanan Mottamal
- Jung Han Yoon ParkJPJung Han Yoon Park
- Soon Sung LimSLSoon Sung Lim
- Ann M. BodeABAnn M. Bode
- Hyong Joo LeeHLHyong Joo Lee
- Ki Won LeeKLKi Won Lee
- Zigang DongZDZigang Dong
Open Access
- 1 December 2013
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 6 (12) , 1293-1303
Abstract
Licorice root is known to possess various bioactivities, including anti-inflammatory and anticancer effects. Glycyrrhizin, a triterpene compound, is the most abundant constituent of dried licorice root. However, high intake or long-term consumption of glycyrrhizin causes several side effects, such as hypertension, hypertensive encephalopathy, and hypokalemia. Therefore, finding additional active compounds other than glycyrrhizin in licorice that exhibit anticancer effects is worthwhile. We found that isoangustone A (IAA), a novel flavonoid from licorice root, suppressed proliferation of human melanoma cells. IAA significantly blocked cell-cycle progression at the G1-phase and inhibited the expression of G1-phase regulatory proteins, including cyclins D1 and E in the SK-MEL-28 human melanoma cell line. IAA suppressed the phosphorylation of Akt, GSK-3β, and JNK1/2. IAA also bound to phosphoinositide 3-kinase (PI3K), MKK4, and MKK7, strongly inhibiting their kinase activities in an ATP-competitive manner. Moreover, in a xenograft mouse model, IAA significantly decreased tumor growth, volume, and weight of SK-MEL-28 xenografts. Collectively, these results suggest that PI3K, MKK4, and MKK7 are the primary molecular targets of IAA in the suppression of cell proliferation. This insight into the biologic actions of IAA provides a molecular basis for the potential development of a new chemotherapeutic agent. Cancer Prev Res; 6(12); 1293–303. ©2013 AACR.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- The role of mitogen‐ and stress‐activated protein kinase pathways in melanomaPigment Cell & Melanoma Research, 2011
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Multitarget drugs: the present and the future of cancer therapyExpert Opinion on Pharmacotherapy, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Herbal Medicines for Liver DiseasesDigestive Diseases and Sciences, 2005
- Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian CancerOncology, 2004
- Cancer Cell CyclesScience, 1996
- D-type cyclinsTrends in Biochemical Sciences, 1995
- Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cellsEuropean Journal of Cancer and Clinical Oncology, 1987
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977